CORDIS
EU research results

CORDIS

English EN
Chaperoning molecular cascades: Hsp90 assisted folding of cell cycle regualting kinases

Chaperoning molecular cascades: Hsp90 assisted folding of cell cycle regualting kinases

Objective

The smooth action of signal transduction cascades is essential prerequisite for higher organisms, and failure here is the major cause of cancer. Crucial for these cascades is assistance by the molecular chaperone Hsp90. It supports protein folding for a su bset of proteins, most of which are oncogenes, and is a cancer drug target itself. Just over 100 substrates are identified to date, more than 50 are kinases, but the specific folding problem of kinases is elusive. We will focus on Cdk kinases, which contro l the cell cycle. They are a homologous family, some of its members require Hsp90, others do not. We set out to establish a new innovative concept to this fundamental question of explaining Hsp90 specificity by selective modulation of kinase stability. We use a multidisciplinary approach combining biopysics, biochemistry and cell biology, applying advanced protein engineering techniques and cutting edge NMR spectroscopy.First, we will analyse the stability of Hsp90-dependent and independent Cdk kinases for full length proteins, kinase domains and fragments thereof, and we will test whether their activation or inactivation influences stability. Second, we will determine under which conditions Cdks bind to Hsp90. We will analyse whether activation processes an d stability influence Hsp90 binding. Third, we want to determine the conformation of Cdk kinase in the Hsp90-bound state. We will map the binding site of Hsp90 in Cdks, and we will follow the kinase's structure throughout the Hsp90 chaperone cycle. Fourth, we will map the binding site of the kinase substrate within Hsp90 and monitor its conformational changes. Finally, we will go into the living cell to identify the structural elements that affect stability of Cdk kinases in vivo. We expect to provide a new paradigm for the chaperoning of oncogenic kinases that will inspire basic research and delivers vital progress for cancer studies.'

Coordinator

UNIVERSITEIT UTRECHT

Address

Heidelberglaan 8
Utrecht

Netherlands

Administrative Contact

Stefan RUDIGER (Dr)

Project information

Grant agreement ID: 25651

  • Start date

    1 April 2006

  • End date

    31 March 2010

Funded under:

FP6-MOBILITY

Coordinated by:

UNIVERSITEIT UTRECHT

Netherlands